|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0318 USD | -6.47% |
|
+8.90% | +22.31% |
| 05-18 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Neutral |
| Resistance | 0.0417 | 0.0417 | 0.2001 |
| Spread/Res. | -23.74% | -23.74% | -84.11% |
| Spread/Supp. | +15.22% | +2,020.00% | +2,020.00% |
| Support | 0.0276 | 0.0015 | 0.0015 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ADAPY Stock
- Charts Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
